secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001479681-24-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q3: Revenue $78.8M (+26%), Adj EBITDA $13.5M (+938%), Operating income positive
--------------------------------------------------------------------------------

- Q3 total revenue $78.8M vs $62.7M YoY (+26%); mature hospitals grew 20.7%.
- Operating income $9.7M vs loss of $0.8M; includes $2.0M non-cash stock comp.
- Adjusted EBITDA attributable to Nutex $13.5M vs $1.3M (+938% YoY).
- Net loss attributable $8.8M (incl. $6.7M non-cash warrant loss) vs $5.5M loss.
- Hospital visits 41,668 (+11.3%); nine-month operating cash flow $23.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000016/0001479681-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000016/nutx-20241107x8k.htm
  HTML page:      https://secwatch.observer/filing/0001479681-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer